Investors in Venture

We believe in the power of climate neutral economic development in Africa. For the last decade, we have been working hand in hand with exceptional entrepreneurs, investing both financial and human capital to build successful climate ventures on the continent. Our companies offer competitive financial returns required to drive lasting impact.

As a student-run venture capital fund, we provide students from Swiss higher education with personalized feedback and support, demystify the funding process, and invest 25'000 CHF in their startups. Vision Educating the next generation of investors that make an impact on the ecosystem and give rise to breakthrough ideas of the next generation. Mission Fostering a cross-campus culture, diversity, and boldness to bring change into society by backing breakthrough ideas coming out of the universities. We see it as a strength that the student-run team changes every 1-2 years as it enables us to touch more people and disseminate the impact into the world.

For over forty years, we have been providing capital support to startups, SMEs, and mid-sized companies, enabling them to grow, innovate, and transform. As a subsidiary of Crédit Mutuel Alliance Fédérale, France's leading "mission-based bank," we believe in giving entrepreneurs the necessary time to achieve their vision. Alongside them, we invest our own funds (€4 billion), which provides us with the flexibility and autonomy to support them over the long term. Each of the 350 companies we support is unique in terms of size, sector, maturity, project, and culture.

We support the builders of critical Web3 infrastructure. We help design products, protocols, and tokens. We are technical and hands-on investors with roots in Europe.

Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow’s standard of care to cure cancer & infectious diseases and improve patient quality of life.

At AFI Ventures, we are committed to supporting the most promising seed and pre-seed impact entrepreneurs. From climate action to promoting healthy living, we partner with every visionary who shares our ambition for deep, scalable impact. We invest up to €500k in 1 to 2 companies every month, empowering these entrepreneurs to achieve their goals. AFI Ventures serves as the seed fund of Alliance for Impact, Europe's leading impact launchpad. How can our support help drive your impactful vision forward?

An early-stage venture capital investment firm.Black Capital Ventures is a high-tech startup advisory partner and green venture capital fund dedicated to investing in a better world. Specializing in GreenTech and MedTech startups, we provide strategic growth support, tools, insights, and a network.

We invest in innovative private early- to mid-stage human Life Science companies that address important medical needs with novel technologies or products backed by compelling science and with differentiated advantages over current treatment options. Our focus is on Switzerland and surrounding EU countries Germany, Austria, France, Italy and Benelux. We mostly invest in drug development and, to a lesser degree, in diagnostics and medical technology. The amount we aim to invest over the life time of our portfolio companies is up to CHF 10 million.

European Internet Ventures is an internet advisory firm focused on online classifieds and marketplaces. Funding Growth EIV raises growth capital for fast-growing marketplace businesses. We work on Series A and all later rounds, with some transactions exceeding $100 million. Full or Partial Exits​ We arrange exits to financial buyers, such as PE and investment funds with strong marketplace credentials, and we find strategic buyers and structure cash and earn-out deals. M&A We support strategic and financial buyers by finding targets, performing due diligence and running the transaction process.

We help you make your businesses extraordinary so that they can be a part of the distinguished organizations of tomorrow. With us by your side, you will be able to enormously enhance your business through our collective ingenuity and hard work.

Today's aseptic and fresh carton packages are not only the best packaging solutions out there in carbon footprint, but also they are so much more sustainable than they were just a few short years ago. Stand-up pouches (SUP) and bag-in-box solutions (BIB) also are greatly increasing their sustainability profile by moving towards mono-material solutions. But we want to stretch the envelope and define future packaging, together with promising start-ups.

Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio. A dozen investment professionals identify the most promising digital, tangible, and health & bio startups. Verve Ventures provides its pan-European network of selected private and institutional investors access to those top-tier investment opportunities. The company invests from EUR 500k to several million from Seed to Series B and beyond across Europe. Verve Ventures' dedicated team helps startups with their most pressing needs such as hiring, client introductions and access to an expert network of high-profile individuals. To become part of Verve Ventures' growing network of entrepreneurs and investors, visit verve.vc.